Eli Lilly investors and analysts said they want to hear details from the company on how exactly it plans to grow U.S. sales ...
If you're trying to lose weight, there are a few things you can do that will help target specific areas of your body - and it ...
A new study examines how cost, side effects, and other factors influence whether people stop GLP-1s, while Noom cuts staff to ...
The use of blockbuster weight loss drugs has surged among young women, for whom the treatments can often be "liberating." ...
When Jeanne began to seriously consider taking Zepbound, one of the new-generation weight-loss drugs, she had the briefest of ...
New research uncovers hidden risks and surprising benefits of weight loss drugs like Ozempic, reshaping how we see these ...
Nearly 2 in 3 people without diabetes quit popular weight loss drugs such as Ozempic or Victoza within one year, according to ...
Hitting a weight loss plateau can feel like running into a brick wall on a road you’ve been traveling so diligently. You’ve ...
Study researcher Dr. Akira Takahashi, head of medicine at Tesseikai Neurosurgical Hospital in Osaka, Japan, conducted the ...
Is compounded semaglutide effective for weight loss? Here’s the short version: Compounded semaglutide isn’t approved by the ...
Cost is a major obstacle for many. The drugs can be expensive without insurance, with out-of-pocket expenses reaching ...
Novo Nordisk (NVO) reported better-than-expected operating profits for Q4 2024 on Wednesday, thanks mainly to its GLP-1 drugs, including its popular weight loss therapy Wegovy, which added DKK 19.9B ...